Axogen, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Axogen, Inc. (AXGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 1.21 million shares for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2020-05-06
- Axogen, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-03-31 was 1.21M shares, a 650.00% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-06-30 was 123.37K shares, a 8.25% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-03-31 was 161.72K shares, a 203.99% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2012 was 267.58K shares, a 76.57% decline from fiscal 2011.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2011 was 1.14M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | 1.21M shares 10-Q · filed 2020-05-06 | ||||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 123.37K shares derived: sum of 2 quarters · filed 2019-11-06 | 285.09K shares 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | 123.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 285.09K shares 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | 161.72K shares 10-Q · filed 2020-05-06 | 161.72K shares 10-Q · filed 2019-05-08 | |||
| 2018-09-30 | 156.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | 270.47K shares derived: sum of 2 quarters · filed 2018-10-29 | 323.67K shares 10-Q · filed 2018-10-29 | ||
| 2018-06-30 | 113.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 167.17K shares 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | 53.20K shares 10-Q · filed 2018-04-30 | ||||
| 2012-12-31 | 267.58K shares 10-K/A · filed 2013-08-07 | ||||
| 2011-12-31 | 1.14M shares 10-K/A · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |